HCPCS code J7314: Yutiq implant, per 0.01 mg2026 Medicare rate & RVUs

Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.

What J7314 covers

Yutiq is a sustained-release fluocinolone acetonide implant placed inside the eye by intravitreal injection. Ophthalmologists, often retina specialists, use it to treat chronic noninfectious uveitis affecting the posterior segment. The drug code identifies the implant; the injection procedure may be reported separately when applicable. Documentation should identify the product and the amount administered.

J7314 is excluded from the physician fee schedule under status E. When Medicare covers the item, payment is made under another method: CMS classifies it as a Part B drug, generally priced through the quarterly Average Sales Price drug files. Coverage is left to the Medicare contractor’s judgment. Each HCPCS unit represents 0.01 mg of fluocinolone acetonide; one 0.18 mg Yutiq implant represents 18 units.

This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.

Where J7314 pays more and less

The same RVUs, adjusted for each area’s costs. Open a locality for its calculation, history and nearby areas.

109 of 109 payment localities

J7314 rates by state

Office rate range in each state. Select a state to see its payment localities.

How the J7314 rate is calculated

Each of J7314’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.

Payment rules and modifiers for J7314

J7314 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.

J7314 compared with similar codes

How to choose

J7311Retisert implantPer 0.01 mg

Use J7314 for the Yutiq fluocinolone implant and J7311 for Retisert. The products have different implant designs and should not be selected interchangeably based only on the shared drug ingredient.

J7313Iluvien implantPer 0.01 mg

J7313 identifies the Iluvien fluocinolone implant, commonly associated with diabetic macular edema. J7314 identifies Yutiq, used for chronic noninfectious uveitis affecting the posterior segment.

J7312Dexamethasone implantPer 0.1 mg

J7312 is for a dexamethasone intravitreal implant, not fluocinolone. Select the code for the specific implant product administered.

Codes related to J7314

Related codes aren’t interchangeable: bill the code that matches the service performed.

Where these rates come from

FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.

CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027

Open CMS sourceHow we calculate rates